Dear Editor,

Nipah virus (NiV) poses a significant threat to global health security due to its high fatality rate and the possibility of human-to-human transmission.1 This zoonotic virus can cause serious effect in both animals and humans.2 Although there are currently no approved vaccines or therapeutics for NiV, there have been promising advances in vaccine development in recent years, bringing us one step closer to curbing the impact of this deadly disease. NiV outbreaks have been reported in several countries in southern Asian countries in support of their statement, outbreaks are taken place annually in Bangladesh.3 The main route of transmission to human is through contact with infected animals, particularly, flying fox (Pteropus) natural reservoir of the virus. However, raising concerns about the pandemic potential of the virus and their impact on human-to-human transmission has also been documented.4